Haloprogin: mode of action studies in Candida albicans.
D000666:Amphotericin B / Q000494:pharmacology; D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D002250:Carbon Radioisotopes; D002462:Cell Membrane / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004912:Erythrocytes / Q000276:immunology; D005656:Fungal Proteins / Q000096:biosynthesis; D006461:Hemolysis / Q000187:drug effects; D007930:Leucine / Q000378:metabolism; D009761:Nystatin / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D010647:Phenyl Ethers / Q000494:pharmacology*; D011188:Potassium / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis; D051381:Rats / Q000276:immunology; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D000935:Antifungal Agents; D002250:Carbon Radioisotopes; D005656:Fungal Proteins; D010647:Phenyl Ethers; D014316:Tritium; D009761:Nystatin; D012313:RNA; D000666:Amphotericin B; D007930:Leucine; D011188:Potassium; D014529:Uridine